Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Uterine Fibroids Clinical Trials

A listing of Uterine Fibroids medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (33) clinical trials

The primary objective of this study is to show superiority of vilaprisan in the treatment of heavy menstrual bleeding (HMB) in subjects with uterine fibroids compared to placebo. The secondary objectives of this study are to additionally evaluate the efficacy and safety of vilaprisan in subjects with uterine fibroids.

Phase

A Pilot Study of Geriatric Specific Interventions for Quality of Life in Elderly Patients With Cancer

The purpose of this study is to examine whether psychoeducation counseling for older cancer patients undergoing treatment is feasible and worthwhile. The investigators will test this in a group or individual phone counseling format. Many cancer patients seek counseling to help with the emotional burden of their illnesses. Counseling often ...

Phase N/A

The Efficacy and Safety of Preoperative Misoprostol in Blood-loss Reduction During Myomectomy.

Uterine fibroids are the commonest benign gynecological tumors in pre-menopausal women affecting over 80% of African women by age of 50. Myomas are clinically apparent in approximately 12 to 25% of reproductive age women and noted coincidentally on pathological examination in approximately 80% of surgically excised uteri. Fibroids; clinically apparent ...

Phase

Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis

Recent studies indicate that mTOR pathway is a specific and sensitive tumor target molecule in uterine fibroids, which can be used as a target molecule for interventional therapy and can provide a new cut-in point for nonoperative treatment. However, the application of mTOR inhibitor (sirolimus) in the treatment of uterine ...

Phase

Aromatase Plus GnRH Analogue Versus Ulippristal Acetate in Uterine Fibroids

Recently it has been introduced the Ulipristal acetate as medical treatment for symptomatic uterine fibroid. The investigators used in the past for the treatment of other benign gynecological diseases such as endometriosis and adenomyosis a combined therapy with Aromatase inhibitor plus GnRH analog. The investigators also used this combined treatment ...

Phase

Ulipristal Acetate Versus GnRH Analogue Treatment Before Hysteroscopic Resection of Uterine Leiomyoma

The uterine leiomyoma is the most common benign tumor of the female genital tract. The myomas are usually clinically apparent in 25% of patients. Submucosal fibroid are about 10% of all uterine myoma; they distort the endometrial cavity causing heavy and/or irregular bleeding (AUB) and infertility. According to the degree ...

Phase

Laparoscopic Myomectomy Using Barbed or Conventional Sutures

Uterine leiomayomas are the most common pelvic tumors in women. About 25% of uterine fibroids causes symptoms such as bleeding , pain ,infertility , recurrent abortion and pelvic pressure symptoms . Surgery is the main line of treatment of symptomatic uterine fibroids. Hysterectomy is the typical management for patients who ...

Phase

Ulipristal Acetate for the Preoperative Management of Hypoechoic Cellular Leiomyomas

Rationale why study should be conducted: Leiomyomas are the most common benign neoplasm in women; it has been estimated that these tumors occur in at least 25% of all women, which is probably an underestimation, because this figure is based on a select population. They are histologically composed by smooth ...

Phase

Satisfaction of Patients With Trans-Arterial Radial Access: Quality of Life in Uterine Fibroid Embolization Trial

1:1 randomized trial comparing patient satisfaction and quality of life with femoral versus radial arterial access for uterine fibroid embolization

Phase N/A

Ovarian Reserve Modification After Lps Hysterectomy With Bilateral Salpingectomy

Ovarian cancer accounts for 3% of all female cancers and represents the fifth leading cause of cancer death in the Western world (1). In 90% of cases, these are epithelial ovarian cancers (2). Because of the biological aggressiveness of this tumor and nonspecific symptoms, that causes a diagnosis at an ...

Phase N/A